| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +16.8M | 99% | $20.00 | +$337M |
| Sells | 9 | -163K | 1% | $18.86 | -$3.08M |
| Net | -8 | +16.7M | 98.1% | +$334M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Roivant Sciences Ltd. | Director, 10%+ Owner | $1.93B | +$337M | +21.1% | Jan 13, 2025 |
| Peter Salzmann | Chief Executive Officer, Director | $17.5M | -$1.14M | -6.12% | Apr 16, 2025 |
| Frank Torti | Director | $16.7M | Apr 1, 2025 | ||
| Julia G. Butchko | Chief Development Officer | $14.3M | Aug 21, 2024 | ||
| Mark S. Levine | Chief Legal Officer | $8.12M | Nov 20, 2024 | ||
| William L. Macias | Chief Medical Officer | $7.45M | -$99.6K | -1.32% | Feb 19, 2025 |
| Eva Renee Barnett | Chief Financial Officer | $5.91M | -$401K | -6.35% | Apr 16, 2025 |
| Melanie Gloria | Chief Operating Officer | $4.16M | -$298K | -6.69% | Nov 20, 2025 |
| Michael Geffner | Chief Medical Officer | $4.15M | -$311K | -6.97% | Oct 22, 2025 |
| Jay Stout | Chief Technology Officer | $3.82M | -$296K | -7.19% | Oct 22, 2025 |
| Christopher Van Tuyl | Chief Legal Officer | $3.21M | Apr 1, 2025 | ||
| Tiago Girao | Chief Financial Officer | $3.06M | May 1, 2025 | ||
| George V. Migausky | Director | $2.74M | Apr 1, 2025 | ||
| Douglas J. Hughes | Director | $2.71M | -$155K | -5.4% | Apr 1, 2025 |
| Atul Pande | Director | $2.45M | -$221K | -8.27% | Apr 1, 2025 |
| Andrew J. Fromkin | Director | $2.16M | -$157K | -6.77% | Apr 1, 2025 |
| Robert Susman | Director | $367K | May 1, 2025 | ||
| Jake Bauer | Director | $367K | May 1, 2025 | ||
| Eric Venker | Chief Executive Officer, Director | Jul 28, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|